Phase 3 Trial of MDMA Therapy for Severe PTSD is So Successful That 67% Don’t Qualify For Diagnosis Now

A breakthrough human trial achieved highly statistically-significant results and an excellent safety record, demonstrating that MDMA-assisted therapy can be an effective treatment for severe and chronic Post-Traumatic Stress Disorder (PTSD).

At the end of the randomized, blinded, Phase…



Click here to view the original article.

Related Posts